Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hutten SJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    MIND the translational gap: Preclinical models of ductal carcinoma in situ.
    Autorzy:
    Hutten SJ; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Jonkers J; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    Clinical and translational medicine [Clin Transl Med] 2023 Aug; Vol. 13 (8), pp. e1376.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Carcinoma, Intraductal, Noninfiltrating*
    Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Autorzy:
    Russo MJ; The Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders, Department of Neurology, Department of Neuroscience and Physiology, Neuroscience Institute, The Parekh Center for Interdisciplinary Neurology, NYU Grossman School of Medicine, New York, NY, USA.
    Orru CD; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
    Concha-Marambio L; R&D Unit, Amprion Inc., San Diego, CA, USA. .
    Giaisi S; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
    Groveman BR; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
    Farris CM; R&D Unit, Amprion Inc., San Diego, CA, USA.
    Holguin B; R&D Unit, Amprion Inc., San Diego, CA, USA.
    Hughson AG; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
    LaFontant DE; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
    Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
    Cofey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
    Mollon J; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
    Hutten SJ; Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Merchant K; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Heym RG; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany. .
    Soto C; R&D Unit, Amprion Inc., San Diego, CA, USA. .; Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas Houston Medical School, Houston, TX, USA. .
    Caughey B; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA. .
    Kang UJ; The Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders, Department of Neurology, Department of Neuroscience and Physiology, Neuroscience Institute, The Parekh Center for Interdisciplinary Neurology, NYU Grossman School of Medicine, New York, NY, USA. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2021 Nov 26; Vol. 9 (1), pp. 190. Date of Electronic Publication: 2021 Nov 26.
    Typ publikacji:
    Published Erratum
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Autorzy:
    Russo MJ; The Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders, Department of Neurology, Department of Neuroscience and Physiology, Neuroscience Institute, The Parekh Center for Interdisciplinary Neurology, NYU Grossman School of Medicine, New York, NY, USA.
    Orru CD; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
    Concha-Marambio L; R&D Unit, Amprion Inc., San Diego, CA, USA. .
    Giaisi S; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
    Groveman BR; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
    Farris CM; R&D Unit, Amprion Inc., San Diego, CA, USA.
    Holguin B; R&D Unit, Amprion Inc., San Diego, CA, USA.
    Hughson AG; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
    LaFontant DE; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
    Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
    Coffey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
    Mollon J; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
    Hutten SJ; Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Merchant K; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Heym RG; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany. .
    Soto C; R&D Unit, Amprion Inc., San Diego, CA, USA. .; Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, University of Texas Houston Medical School, Houston, TX, USA. .
    Caughey B; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA. .
    Kang UJ; The Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders, Department of Neurology, Department of Neuroscience and Physiology, Neuroscience Institute, The Parekh Center for Interdisciplinary Neurology, NYU Grossman School of Medicine, New York, NY, USA. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2021 Nov 06; Vol. 9 (1), pp. 179. Date of Electronic Publication: 2021 Nov 06.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Parkinson Disease/*diagnosis
    alpha-Synuclein/*genetics
    Aged ; Biomarkers ; Disease Progression ; Female ; Gene Amplification ; Humans ; Male ; Middle Aged ; Parkinson Disease/genetics ; Prognosis ; Prospective Studies ; Reproducibility of Results ; Sensitivity and Specificity ; Terminology as Topic ; Tomography, Emission-Computed, Single-Photon ; alpha-Synuclein/cerebrospinal fluid
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    Autorzy:
    Bartl M; Department of Neurology, University Medical Center Goettingen, Goettingen, Germany.
    Dakna M; Department of Neurology, University Medical Center Goettingen, Goettingen, Germany.
    Galasko D; Department of Neurosciences, University of California, San Diego, San Diego, CA, United States of America.
    Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, United States of America.
    Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States of America.
    Quan M; Roche Diagnostics, Indianapolis, IN, United States of America.
    Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, United States of America.
    Siderowf A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
    Franz J; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.; Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany.; Max Planck Institute for Experimental Medicine, Göttingen, Germany.
    Trenkwalder C; Paracelsus-Elena-Klinik, Kassel, Germany.; Department of Neurosurgery, University Medical Center Goettingen, Goettingen, Germany.
    Mollenhauer B; Department of Neurology, University Medical Center Goettingen, Goettingen, Germany.; Paracelsus-Elena-Klinik, Kassel, Germany.
    Pokaż więcej
    Corporate Authors:
    Parkinson’s Progression Markers Initiative
    Źródło:
    PloS one [PLoS One] 2021 Oct 07; Vol. 16 (10), pp. e0257372. Date of Electronic Publication: 2021 Oct 07 (Print Publication: 2021).
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Alzheimer Disease/*cerebrospinal fluid
    Neuroglia/*pathology
    Parkinson Disease/*cerebrospinal fluid
    Adult ; Aged ; Aged, 80 and over ; Alzheimer Disease/pathology ; Biomarkers/cerebrospinal fluid ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Parkinson Disease/pathology ; alpha-Synuclein/cerebrospinal fluid
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy.
    Autorzy:
    Orrù CD; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana.
    Ma TC; Department of Neurology, New York University Grossman School of Medicine, New York, New York.
    Hughson AG; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana.
    Groveman BR; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana.
    Srivastava A; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana.
    Galasko D; Department of Neurosciences, University of California-San Diego, La Jolla, California.
    Angers R; UCB Biopharma SRL, Braine l'Alleud, Belgium.
    Downey P; UCB Biopharma SRL, Braine l'Alleud, Belgium.
    Crawford K; Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
    Hutten SJ; Michael J. Fox Foundation, New York, New York.
    Kang UJ; Department of Neurology, New York University Grossman School of Medicine, New York, New York.
    Caughey B; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana.
    Pokaż więcej
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Feb; Vol. 8 (2), pp. 374-384. Date of Electronic Publication: 2020 Dec 29.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biological Assay/*methods
    Biomarkers/*cerebrospinal fluid
    Parkinson Disease/*cerebrospinal fluid
    Parkinson Disease/*diagnosis
    alpha-Synuclein/*cerebrospinal fluid
    Aged ; Correlation of Data ; Female ; Humans ; Male ; Middle Aged ; Parkinson Disease/physiopathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder.
    Autorzy:
    Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
    Brumm MC; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Oertel W; Department of Neurology, Philipps University, Marburg, Germany.
    Mollenhauer B; Department of Neurology, University Medical Center Goettingen, Goettingen, Germany.; Paracelsus-Elena-Klinik, Kassel, Germany.
    Amara A; Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
    Fernandez-Arcos A; Neurology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
    Tolosa E; Neurology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
    Simonet C; Neurology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
    Hogl B; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
    Videnovic A; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
    Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
    Tanner C; Department of Neurology, University of California San Francisco, San Francisco, California, USA.
    Weintraub D; Departments of Neurology Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Burghardt E; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Coffey C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Cho HR; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Kieburtz K; University of Rochester Medical Center, University of Rochester, Rochester, NY, USA.
    Poston KL; Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
    Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    Galasko D; Department of Neurology, University of California, San Diego, California, USA.
    Foroud T; Department of Medical & Molecular Genetics, Indiana University, Indianapolis, Indiana, USA.
    Siderowf A; Departments of Neurology Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Marek K; Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA.
    Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    Iranzo A; Neurology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
    Pokaż więcej
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jan; Vol. 8 (1), pp. 201-212. Date of Electronic Publication: 2020 Dec 15.
    Typ publikacji:
    Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Dopamine Plasma Membrane Transport Proteins/*metabolism
    REM Sleep Behavior Disorder/*complications
    REM Sleep Behavior Disorder/*diagnostic imaging
    Synucleinopathies/*diagnostic imaging
    Aged ; Female ; Humans ; Male ; Middle Aged ; Tomography, Emission-Computed, Single-Photon/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
    Autorzy:
    Alcalay RN; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
    Wolf P; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
    Chiang MSR; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
    Helesicova K; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
    Zhang XK; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
    Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
    Scherzer C; Advanced Center for Parkinson's Disease Research of Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Precision Neurology Program, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
    Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
    Foroud T; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Nudelman K; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Gan-Or Z; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.; Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
    Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
    Levy O; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
    Zheng D; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
    Li G; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
    Sardi SP; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
    Pokaż więcej
    Corporate Authors:
    Parkinson’s Progression Markers Initiative
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Oct; Vol. 7 (10), pp. 1816-1830. Date of Electronic Publication: 2020 Sep 05.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Dementia/*physiopathology
    Glucosylceramidase/*metabolism
    Parkinson Disease/*metabolism
    Parkinson Disease/*pathology
    Adult ; Dementia/complications ; Dementia/pathology ; Disease Progression ; Female ; Genotype ; Glucosylceramidase/genetics ; Heterozygote ; Humans ; Male ; Mental Status and Dementia Tests ; Middle Aged ; Mutation/genetics ; Parkinson Disease/complications ; Phenotype
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 Cohorts.
    Autorzy:
    Padmanabhan S; The Michael J Fox Foundation for Parkinson's Research, NY, USA.
    Lanz TA; Pfizer Inc., Groton, CT, USA.
    Gorman D; Pfizer Inc., Cambridge, UK.
    Wolfe M; Quanterix, Billerica, MA, USA.
    Joyce A; Pfizer Inc., Andover, MA, USA.
    Cabrera C; Pfizer Inc., Andover, MA, USA.
    Lawrence-Henderson R; Pfizer Inc., Andover, MA, USA.
    Levers N; Department of Neurology, Columbia University, NY, USA.
    Joshi N; Department of Neurology, Columbia University, NY, USA.
    Ma TC; Department of Neurology, Columbia University, NY, USA.
    Liong C; Department of Neurology, Columbia University, NY, USA.
    Narayan S; Department of Neurology, Columbia University, NY, USA.
    Alcalay RN; Department of Neurology, Columbia University, NY, USA.
    Hutten SJ; The Michael J Fox Foundation for Parkinson's Research, NY, USA.
    Baptista MAS; The Michael J Fox Foundation for Parkinson's Research, NY, USA.
    Merchant K; TransThera Consulting Co, Portland, OR, USA.
    Pokaż więcej
    Źródło:
    Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (2), pp. 623-629.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/*metabolism
    Leukocytes, Mononuclear/*metabolism
    Parkinson Disease/*blood
    Parkinson Disease/*genetics
    Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics ; Male ; Middle Aged ; Phosphorylation/physiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
    Autorzy:
    Merchant KM; Vincere Biosciences, Inc., and Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Cedarbaum JM; Biogen, Cambridge, MA, USA.
    Brundin P; Van Andel Research Institute, Center for Neurodegenerative Science, Grand Rapids, MI, USA.
    Dave KD; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Eberling J; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Espay AJ; UC Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, OH, USA.
    Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Javidnia M; Center for Health and Technology, University of Rochester Medical Center, Rochester, New York, USA.
    Luthman J; Eisai, Woodcliff Lake, NJ, USA.
    Maetzler W; Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
    Menalled L; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Reimer AN; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
    Stoessl AJ; Djavad Mowafaghian Centre for Brain Health, Pacific Parkinson's Research Center, University of British Columbia, Vancouver, BC, Canada.
    Weiner DM
    Pokaż więcej
    Corporate Authors:
    The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group
    Źródło:
    Journal of Parkinson's disease [J Parkinsons Dis] 2019; Vol. 9 (1), pp. 31-61.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biomarkers*
    Clinical Trials as Topic*
    Disease Models, Animal*
    Guidelines as Topic*
    Proof of Concept Study*
    Translational Research, Biomedical*
    Parkinson Disease/*drug therapy
    alpha-Synuclein/*drug effects
    Animals ; Consensus ; Humans ; Parkinson Disease/diagnosis ; Research Design
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Visualization of BRI1 and SERK3/BAK1 Nanoclusters in Arabidopsis Roots.
    Autorzy:
    Hutten SJ; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Hamers DS; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Aan den Toorn M; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    van Esse W; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Nolles A; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Bücherl CA; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    de Vries SC; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Hohlbein J; Laboratory of Biophysics, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.; Microspectroscopy Centre, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Borst JW; Laboratory of Biochemistry, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.; Microspectroscopy Centre, Wageningen University & Research, Stippeneng 4, WE Wageningen, The Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 Jan 23; Vol. 12 (1), pp. e0169905. Date of Electronic Publication: 2017 Jan 23 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Nanostructures*
    Arabidopsis/*metabolism
    Arabidopsis Proteins/*metabolism
    Plant Roots/*metabolism
    Protein Kinases/*metabolism
    Protein Serine-Threonine Kinases/*metabolism
    Fluorescence Resonance Energy Transfer
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies